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S U M M A R Y
Objectives: To evaluate prevalences of Treponema pallidum, human immunodeﬁciency virus (HIV),
human T-lymphotropic virus (HTLV), and hepatitis B virus (HBV) infections and coinfections during
prenatal screening in an urban Northeastern Brazilian population through a large dataset.
Methods: Secondary data were obtained from the Maceio´ (Alagoas, Brazil) municipal prenatal screening
program from June 2007 to May 2012. Dried blood serum tests from 54,813 pregnant women were
examined to determine prevalences of T. pallidum, HIV, HTLV, and HBV infections and coinfections, and
the seroconversion rates for syphilis and HIV infection. Socio-demographic variables associated with
syphilis and HIV infection were identiﬁed.
Results: The prevalences of syphilis, HIV, HTLV, and HBV infections were 2.8%, 0.3%, 0.2%, and 0.4%,
respectively. Pregnant women infected with T. pallidum had a 4.62-fold greater risk of HIV coinfection,
and pregnant women infected with HIV had a 5.71-fold greater risk of T. pallidum coinfection.
Seroconversion for syphilis and HIV during pregnancy occurred in 0.5% and 0.06% of women,
respectively. Among the women carrying HTLV, 4.2% also had an HBV infection.
Conclusions: Syphilis was twice as prevalent among pregnant women in Maceio´, compared to the
national average, and coinfections with syphilis/HIV and HTLV/HBV were signiﬁcantly associated among
these pregnant women.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Early diagnosis and proper management during pregnancy and
after childbirth can reduce mother-to-child transmission of
syphilis, the human immunodeﬁciency virus (HIV), the human
T-cell lymphotropic virus (HTLV), and the hepatitis B virus
(HBV).1,2 Approximately 1.5 million pregnant women worldwide
are infected with Treponema pallidum annually; if untreated, 50% of
them will experience adverse events, including stillbirth, prema-
turity, and deaths.3 Furthermore, in 2006, the World Health* Corresponding author. Universidade Federal de Alagoas, Av. A´lvaro Otacı´lio,
6491/603, Jatiu´ca, Maceio´/AL, Brazil. Tel.: +558299026148.
E-mail address: adriana_avila@uol.com.br (A.A. Moura).
http://dx.doi.org/10.1016/j.ijid.2015.07.022
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Organization reported that 2.3% of pregnant women tested positive
for HIV infections in low-and middle-income countries.4 Thus, the
elimination of mother-to-child transmission of HIV and syphilis
have been incorporated into the World Health Organization’s
Millennium Development Goals 4, 5, and 6.5 To achieve these goals,
prenatal screening is critical to preventing mother-to-child
transmission via interventions during pregnancy, childbirth, and
the post-partum period.4,5
An estimated 240 million individuals worldwide are infected
with HBV, with a male:female distribution ratio of approximately
1.5:1.6 Based on these statistics, we can assume that there are
approximately 90 million female carriers of HBV, many of whom
are of childbearing age. Their babies can also become chronic
carriers of the HBV s-antigen (HBsAg) if they do not receive
preventative treatment.7 In addition, these individuals have aciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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the identiﬁcation of pregnant women who are carriers of HBsAg is
an important strategy for preventing mother-to-child transmis-
sion.7
An estimated 15–20 million people worldwide are infected
with HTLV-1 or HTLV-2,8 and mother-to-child transmission
typically occurs during breastfeeding.8 There are no national data
regarding the number of pregnant women who are carriers of HTLV
in Brazil, and the Ministry of Health does not currently recommend
prenatal screening for HTLV.9 However, because they have
common transmission routes, increases in the prevalences of
syphilis and infection with HIV, HTLV, and HBV can overlap. In
addition, their magnitude and vulnerability to preventive methods
during pregnancy makes them global public health concerns
(albeit to differing degrees).10 Therefore, we conducted this large
study to determine the prevalences of syphilis and HIV, HTLV, and
HBV infections and coinfections during prenatal screening among
pregnant women in an urban Northeastern Brazilian population. In
addition, we evaluated the seroconversion rates of syphilis and HIV
infection, and evaluated the association between various socio-
demographic variables and syphilis or HIV infection.
2. Materials and methods
This study used a descriptive, observational, cross-sectional
design to evaluate data from the Maceio´ antenatal infectious
diseases screening registry. The Maceio´ Municipal Health Ofﬁce
authorized the use of these data (July 2012) and the ethics
committee of the Instituto de Medicina Integral Prof. Fernando
Figueira approved the study design (CAAE: 06733812.2.0000.5201;
Plataforma Brasil).
2.1. Population, prenatal testing, data collection, and processing
Maceio´, the capital of the State of Alagoas, is located in
northeastern Brazil and had 76,862 births between June 2007 and
May 2012.11 Based on an average miscarriage rate of 16% in
northeastern Brazil,12 it was estimated that 89,159 pregnancies
occurred in Maceio´ during this period. Approximately 74.7% of the
population are public healthcare users,13 which indicates that
more than 66,600 of the pregnant mothers received public
healthcare.
Between June 2007 and May 2012, 54,813 pregnant women
who sought treatment at the Maceio´ Universal Healthcare System
(Sistema U´nico de Sau´de, SUS) were screened for T. pallidum, HIV,
HTLV, and HBV infections during their ﬁrst prenatal care visit. The
Municipal Health Ofﬁce antenatal disease screening program
screened 61.4% of all pregnancies in the municipality, and 82.3% of
pregnancies that received prenatal care via the public healthcare
system during this period. The evaluation form for the included
women recorded their date of birth, self-reported ethnicity,
number of abortions, gestational age at the ﬁrst prenatal visit,
and district of residence, based on the 7 health districts in Maceio´.
Those health districts are deﬁned using common geographic
characteristics, and have signiﬁcant urban social inequalities.14
The screening program consisted of collecting capillary blood
samples via S&S #903 ﬁlter paper (Schleicher & Schuell, Keene,
NH) for serological testing at the laboratory of the Instituto de
Pesquisa e Diagno´stico Laboratorial of the Association of Parents
and Friends of Handicapped Children of Maceio´ (Associac¸a˜o de Pais
e Amigos dos Excepcionais: APAE Maceio´). In this laboratory, the
blood samples were re-suspended for enzyme-linked immuno-
sorbent assay (ELISA) testing for anti-T. pallidum antibodies, anti-
HTLV antibodies, HBsAg, anti-HBc antibodies, and anti-HIV
antibodies, according to the manufacturer’s speciﬁcations. The
speciﬁc kits were the Q-Preven Total Syphilis-DBS, Q-Preven HIV1+2-DBS, Q-Preven HTLV-1+2-DBS, and Q-Preven HBsAg-DBS,
which are manufactured by Symbiosis Diagno´stica Ltd (Sa˜o Paulo,
Brazil). When a woman tested positive for any of these tests, a
second peripheral blood sample was collected and analyzed via
conventional testing at the same laboratory to conﬁrm the
preliminary ﬁndings. Pregnant women were considered to be
infected with T. pallidum based on the Venereal Disease Research
Laboratory (VDRL) test (any titer), with HIV based on ELISA and
western blot (WB) anti-HIV testing, with HTLV-1 and -2 based on
ELISA and WB anti-HTLV-1 and -2 testing, and with HBV based on
anti-HBc and HBsAg ELISA testing. Only pregnant women who
underwent the entire diagnostic procedure for each disease were
included in our analyses. During the third trimester, capillary
blood was collected again to screen for syphilis and HIV infection,
using the same criteria (Figure 1).
2.2. Data analysis
Statistical analyses were performed using Stata software
(version 12.1, StataCorp LP, College Station, TX, USA), and
differences with a p-value of <0.05 were considered statistically
signiﬁcant. The analyzed variables included the prevalences of
syphilis, HIV, HTLV, and HBV infections, and the seroconversion
rates for syphilis and HIV infections. The prevalences of syphilis
and HIV infection were tested for associations with age group (19
years old or >19 years old), self-reported ethnicity (mixed race,
white, black, or Asian), number of miscarriages (<2 or 2),
beginning of prenatal care (<12 weeks of gestation or 12 or more
weeks of gestation), and the district of residence (Maceio´ health
district 1–7). Differences between proportional data were com-
pared using the chi-square test, and variables with a p-value of
0.20 in the univariate analyses were included in the multivariate
model.
3. Results
Among 54,813 pregnant women who provided capillary blood
samples during their ﬁrst trimester, 54,744 (99.9%) were tested for
syphilis, 54,811 (99.9%) were tested for HIV infection, 54,798
(99.9%) were tested for HTLV infection, and 54,798 (99.9%) were
tested for HBV infection. The birth date was reported by 99.6% of
the participants, ethnicity by 92.6%, beginning of prenatal care by
85.1%, number of abortions by 75.3%, and district of residence by
85.1%. The average age was 23.3  6.1 years (95% conﬁdence
interval [CI]: 15–35 years), and 31.5% of the participants were
adolescents (19 years old). Pregnant women self-reported their
ethnicity as mixed race (68.3%), white (21.8%), black (8.8%), or Asian
(1%). Gestational age at the beginning of prenatal care was
16.4  7 weeks (95% CI: 8–30 weeks), and 34% of the participants
began their prenatal care at 12 weeks of gestation.
Table 1 lists the prevalences of syphilis, HIV, HTLV, and HBV
infections according to the participants’ socio-demographic and
antenatal characteristics. Table 2 lists the general prevalences of
syphilis, HIV, HTLV, and HBV infections. Among the pregnant
women who were seronegative for syphilis or for HIV during their
ﬁrst trimester, 42% and 43% were tested again during their third
trimester, respectively. Seroconversion for syphilis was observed
in 123 (0.5%) of these participants and seroconversion for HIV
occurred in 14 (0.06%) of these participants.
Syphilis was more prevalent among women who were >19
years old, compared to among adolescents (adjusted odds ratio
[aOR]: 1.87; p < 0.001), although age was not signiﬁcantly
associated with HIV prevalence. Syphilis and HIV infections were
more prevalent among self-reported non-white women, compared
to white women (aORs: 1.63 and 1.26, respectively; p < 0.05).
Syphilis was more prevalent among women who began prenatal
Figure 1. Flowchart for the Municipal Health of Maceio´ prenatal screening program during the study period.
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miscarriages (aORs: 1.21 and 1.87, respectively; both p < 0.01),
although there was no signiﬁcant association with the prevalence
of HIV infection. Syphilis was more prevalent among pregnant
women from Maceio´ health districts 2 and 5 (aORs: 1.92 and
1.40 respectively; both p < 0.05), although there were no district-
speciﬁc differences in the prevalences of HIV infection
(Tables 3 and 4).
The overall prevalence of coinfection was 0.08%, and the
proportions of coinfections are listed in Tables 5 and 6. Pregnant
women who were infected with T. pallidum had a 4.62-fold greater
risk of being coinfected with HIV (p < 0.001), and pregnant women
who were infected with HIV had a 5.71-fold greater risk of being
coinfected with T. pallidum (p < 0.001) (Tables 3 and 4). Among
pregnant women with syphilis, 3 (0.5%) seroconverted to HIV
during pregnancy (p < 0.001), and the rate ratio for HIV
seroconversion among these women was 11.02-fold greater than
that among women who did not have syphilis (p < 0.001). One
woman who was infected with HIV seroconverted to syphilis
during pregnancy, and another seroconverted to both HIV andsyphilis during pregnancy. However, HIV and HTLV coinfection
was not observed in the study population.
4. Discussion
The present study’s ﬁndings revealed a syphilis prevalence of
2.8% among pregnant women who underwent prenatal care at
public healthcare facilities in a Northeastern Brazilian capital city,
which is 2.3-fold greater than the prevalence from a national study
(1.20%).15 However, methodological differences in the diagnostic
testing may have contributed to this discrepancy. Disparate
prevalences have been reported in various regions of Brazil, which
indicates a heterogeneous distribution of syphilis.16,17 We also
observed a 0.5% seroconversion rate for syphilis during the third
trimester in Maceio´, which is similar to the reported national
rates.15 Therefore, it is important to perform continued surveil-
lance and counseling of pregnant women during all prenatal care
visits, and to provide treatment for the women and their partners.
In Brazil, the prevalence of HIV infection among pregnant
women is 0.4%,18 although several studies have reported regional
Table 1
Prevalence of syphilis, HIV infection, HTLV infection and HBV infection according to












19 1.4 (17,220) 0.3 (17,231) 0.2 (17,229) 0.3 (17,225)
>19 3.5 (37,329) 0.4 (37,385) 0.2 (37,374) 0.4 (37,378)
p-value* <0.0001 0.1 0.299 0.062
Ethnicity
White 2.3 (11,090) 0.2 (11,108) 0.2 (11,105) 0.4 (11,107)
Non-white 3.0 (39,604) 0.4 (39,651) 0.2 (39,642) 0.4 (39,641)
p-value* <0.0001 0.014 0.566 0.384
Beginning of Prenatal care (weeks)
12 2.3 (15,807) 0.3 (15,827) 0.2 (15,822) 0.4 (15,823)
>12 3.0 (30,763) 0.4 (30,805) 0.2 (30,796) 0.4 (30,798)
p-value* <0.0001 0.052 0.24 0.179
Miscarriage
<2 2.5 (38,649) 0.3 (38,692) 0.2 (38,682) 0.4 (38,684)
>2 7.0 (2,546) 0.5 (2,559) 0.4 (2,557) 0.6 (2,557)
p-value* <0.0001 0.13 0.039 0.262
District of residence
1st district 2.2 (4,533) 0.4 (4,539) 0.2 (4,539) 0.4 (4,540)
2nd district 4.0 (7,580) 0.4 (7,598) 0.4 (7,957) 0.5 (7,596)
3rd district 2.6 (3,882) 0.3 (3,885) 0.1 (3,884) 0.4 (3,885)
4th district 2.3 (5,418) 0.2 (5,425) 0.3 (5,423) 0.3 (5,422)
5th district 3.0 (10,028) 0.3 (10,035) 0.2 (10,033) 0.3 (10,033)
6th district 2.7 (8,152) 0.5 (8,163) 0.3 (8,162) 0.5 (8,158)
7th district 2.6 (13,093) 0.3 (13,107) 0.2 (13,131) 0.4 (13,105)
p-value* <0.001 0.065 0.012 0.528
HIV: human immunodeﬁciency virus, HTLV: human T-lymphotropic virus, HBV:
hepatitis B virus.
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seroprevalence of HIV infection among pregnant women, and a
0.06% seroconversion rate during pregnancy. This seroconversion
rate occurred in a population with approximately 50% coverageTable 2




Syphilis 54,744 2.8 (2.69–2.97) 
HIV infection 54,811 0.3 (0.29–0.39) 
HTLV infection 54,798 0.2 (0.18–0.26) 
HBV infection 54,798 0.4 (0.36–0.47) 
HIV: human immunodeﬁciency virus, HTLV: human T-lymphotropic virus, HBV: hepat
Table 3
Univariate and multivariate analysis of socio-demographic factors that were associated
Univariate analysis 
OR 95% CI 
Age >19 years 2.55 2.22–2.92 
Non-white 1.33 1.17–1.53 
2 miscarriages 2.92 2.48–3.45 
Beginning of prenatal care
(>12 weeks of gestational age)
1.29 1.14–1.46 
District of residence 
1st district 1.00
2nd district 1.83 1.42–2.30 
3rd district 1.20 0.95–1.58 
4th district 1.02 0.78–1.33 
5th district 1.36 1.09–1.72 
6th district 1.24 0.99–1.58 
7th district 1.17 0.93–1.47 
HIV infection 6.17 4.12–9.25 
a The ﬁnal model was adjusted for age group, ethnicity, miscarriages, beginning of pr
virus, OR: odds ratio, CI: conﬁdence interval.during the second test, compared to 15% coverage during the
second test in the national study.18 These ﬁndings reafﬁrm the
consensus that pregnant women should be screened for HIV
infection, and support the recommendation of a HIV second test
during the third semester or delivery, in order to provide effective
interventions that can prevent mother-to-child transmission.1,22
Only ethnicity was associated with HIV infection in our multivari-
ate analysis. This higher HIV infection prevalence among non-
white women is likely due to a lower socioeconomic status, which
is more common among non-white women in Brazil.23
Syphilis and HIV coinfection occurred in 0.05% of the pregnant
women in Maceio´, and our multivariate analysis revealed a strong
risk of HIV-infected pregnant women becoming coinfected with T.
pallidum (aOR: 5.71; p < 0.001). Among pregnant women who had
HIV infection, 15.1% were coinfected with syphilis, which is
approximately 5.5-fold higher than the national study rate (2.85%;
aOR: 4.75).18 Syphilis facilitates HIV infection in several ways, and
coinfection can promote the aggravation and progression of both
diseases.24
We found an HTLV seroprevalence of 0.2% among the screened
pregnant women. Other Brazilian studies have reported seropre-
valences among pregnant women that range from 0.1% to
1.05%.21,25 Prenatal screening for HTLV-1 and -2 infections is not
recommended in populations with a low seroprevalence, despite
there being no available treatment, and the transmission rate is
estimated at 2.7% for non-breastfed infants.2 Therefore, local
seroprevalence studies should be performed to identify at-risk
groups during prenatal care, and this information should be used to
guide policy decisions regarding screening pregnant women for
HTLV.
The prevalence of HBV infection among pregnant women was
0.4% in Maceio´. Previous studies have reported similar prevalences
of 0.3–0.8% among pregnant Brazilian women.19,26 The adminis-
tration of the HBV vaccine and HBV-speciﬁc immunoglobulin
within 12 h of birth increases the efﬁcacy of the prophylactic syphilis and HIV infection among urban pregnant Northeastern Brazilian women





itis B virus, CI: conﬁdence interval.
 with syphilis among urban pregnant Northeastern Brazilian women (2007–2012).
Multivariate analysisa
p OR 95% CI p
0.001 1.87 1.53–2.28 0.001
0.001 1.26 1.06–1.50 0.009
0.001 1.87 1.54–2.27 0.001
0.001 1.21 1.05–1.41 0.009
0.001 0.001
0.001 1.92 1.44–2.64 0.001
0.209 1.39 0.95–1.97 0.069
0.878 1.02 0.71–1.49 0.899
0.007 1.40 1.03–1.89 0.031
0.070 1.34 0.97–1.83 0.073
0.170 1.22 0.90–1.64 0.199
0.001 4.62 2.72–7.84 0.001
enatal care, district of residence and HIV infection. HIV: human immunodeﬁciency
Table 4
Univariate and multivariate analysis of socio-demographic factors that were associated with HIV infection among urban pregnant Northeastern Brazilian women (2007–
2012)
Univariate analysis Multivariate analysis a
OR 95% CI p OR 95% CI p
Age >19 years 1.31 0.95–1.83 0.101
Non-white 1.69 1.11–2.59 0.015 1.63 1.05–2.54 0.030
2 miscarriages 1.55 0.87–2.75 0.133
Beginning of prenatal care
(>12 weeks of gestational age)
1.41 0.99–2.00 0.050
District of residence 0.073
1st district 1.22 0.68–2.18 0.511
2nd district 1.45 0.91–2.33 0.119
3rd district 1.07 0.56–2.04 0.848
4th district 0.70 0.36–1.37 0.296
5th district 1.00 0.61–1.62 0.990
6th district 1.70 1.08–2.64 0.020
7th district 1.00
Syphilis 6.17 4.12–9.25 0.001 5.71 3.75–8.69 0.001
a The ﬁnal model was adjusted for ethnicity and Treponema pallidum infection. HIV: human immunodeﬁciency virus, OR: odds ratio, CI: conﬁdence interval.
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Therefore, routine screening of pregnant women remains impor-
tant in countries where the vaccine is administered, as the
diagnosis of HBV infection can help guide the healthcare team in
administering immunoglobulin to the newborn.
In our data, we infrequently observed cases of coinfection with
syphilis and HBV, syphilis and HTLV, or HBV and HIV; no cases of
HIV and HTLV were reported. HBV and HTLV coinfection occurred
in 0.009% of the participants, and although rare, this association
was statistically signiﬁcant. Among pregnant women who were
infected with HTLV, 4.2% were also carriers of HBV (p < 0.001). We
have found no other studies that have evaluated this association
among pregnant women.
Our multivariate analysis revealed that syphilis was associated
with age (>19 years old), and this increased prevalence among
older women may be related to successive reinfection. Non-white
pregnant women had a higher prevalence of syphilis, which isTable 5
Prevalences of coinfections among urban pregnant Northeastern Brazilian women
(2007–2012).
Coinfection Screened %
Syphilis HIV 54,742 0.050
HTLV 54,729 0.007
HBV 54,729 0.009
HIV HBV 54,796 0.002
HTLV 54,729 0
HTLV HBV 54,783 0.009
HIV: human immunodeﬁciency virus, HTLV: human T-lymphotropic virus, HBV:
hepatitis B virus.
Table 6
Proportion of coinfections with syphilis, HIV, HTLV, and hepatitis B among urban
pregnant Northeastern Brazilian women (2007–2012).
Coinfections (%)
n Syphilis HIV HTLV Hepatitis B
Syphilis 1,550 - 1.8 0.3 0.3
p-value <0.001 0.688 0.581
HIV infection 186 15.1 - 0 0.5
p-value <0.001 0.786
HTLV infection 118 3.4a 0 - 4.2
p-value 0.688 <0.001
Hepatitis B 226 2.2 0.4b 2.2 -
p-value 0.581 0.786 <0.001
a Baseline = 116; b baseline = 225. HIV: human immunodeﬁciency virus, HTLV:
human T-lymphotropic virus, HBV: hepatitis B virus.similar to the national report’s ﬁndings.15 We also found an
association between syphilis and late initiation of prenatal care,
which is considered an independent risk factor for high-risk
pregnancies, and may indicate reduced access to health services,
low education level, or lack of interest or knowledge regarding the
importance of early pregnancy monitoring.28 In this study, syphilis
was associated with the number of abortions (2). Unfortunately,
miscarriages and perinatal or neonatal deaths occur in 40% of
children who are infected via untreated mothers,29 which may also
indicate that these pregnant women are long-time carriers of the
disease. Maceio´ health districts 2 and 5 also had signiﬁcantly
higher syphilis prevalences. Lower income and lower education,
compared to other health districts, may explain those ﬁndings.14
Nevertheless, it is possible that non-assessed factors may also be
responsible for the higher prevalences in those districts. Therefore,
studies are needed to deepen our understanding of these
communities’ characteristics and to deﬁne local public health
strategies that can modify the prevalence of syphilis.
In conclusion, our ﬁndings support continuous screening of
pregnant women for syphilis, HIV, and HBV infection, especially
given the severity of syphilis and HIV coinfection. While our
assessment of associated factors is limited by the small number of
variables that were collected during the routine screening
program, this study concomitantly evaluated 4 infectious diseases
and their coinfections, and determined the seroconversion rates of
two diseases that have high priority in public healthcare.
Furthermore, few other studies have reported the coinfection
rates of infectious diseases among pregnant women. Therefore, as
Maceio´ has urban characteristics and social, economic, and health
service structures that are similar to other medium-sized
Northeastern Brazilian urban centers, our ﬁndings may be relevant
to promote systematic screening of pregnant women in these
centers, and to support appropriate public policies and prevention
strategies to improve individual and societal health.
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